| Customization: | Available |
|---|---|
| CAS No.: | Customization, 388082-78-8 |
| Formula: | Customization, C181h291n55o51s 2 |
|
Still deciding? Get samples of US$ 400/kg
Order Sample
|
| Shipping Cost: | Contact the supplier about freight and estimated delivery time. |
|---|
| Payment Methods: |
|
|---|---|
| Support payments in USD |
| Secure payments: | Every payment you make on Made-in-China.com is protected by the platform. |
|---|
| Refund policy: | Claim a refund if your order doesn't ship, is missing, or arrives with product issues. |
|---|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
Introduction:
Lapatinib ditosylate monohydrate, also known as Lapatinib, is a potent and targeted anticancer medication that belongs to the class of tyrosine kinase inhibitors. It is commonly used in the treatment of certain types of breast cancer that have specific genetic mutations.
With its precise mechanism of action, Lapatinib effectively inhibits the activity of two proteins, namely epidermal receptor (EGFR) and human epidermal receptor 2 (HER2/neu), which are known to play a critical role in the growth and spread of cancer cells. By blocking these proteins, Lapatinib helps to slow down or halt the progression of the disease.
Function:
The efficacy of Lapatinib has been demonstrated through clinical trials and research studies. It has shown promising results in treating HER2-positive breast cancer, particularly in cases where other treatments such as chemotherapy have proven ineffective. In combination with other medications, Lapatinib has the potential to improve patient outcomes and prolong survival rates.
Furthermore, Lapatinib offers hope to patients who have developed resistance to other targeted therapies. By targeting multiple pathways involved in cancer growth, it provides an alternative treatment option for those who have exhausted conventional approaches.
Application:
In terms of application, Lapatinib is primarily used in the management of advanced or metastatic breast cancer. It is often prescribed in combination with hormonal therapies or chemotherapy, depending on the specific characteristics of the tumor and the patient's overall condition. The individual dosage and treatment duration are determined by the healthcare provider, taking into account various factors such as the stage of cancer, the patient's overall health, and any underlying medical conditions.
1. Are you a manufacturer or trading company?
A: We are a manufacturer and welcome to visit our factory.
){kind=link}